Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.245
-0.005 (-0.22%)
At close: Oct 7, 2025, 4:00 PM EDT
2.190
-0.055 (-2.45%)
Pre-market: Oct 8, 2025, 5:15 AM EDT
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $29.59 million as of October 8, 2025. Its market cap has increased by 6.05% in one year.
Market Cap
29.59M
Enterprise Value
27.59M
1-Year Change
6.05%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $29.59M, a decrease of -69.81%. That is a compound annual growth rate of -9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 30.30M | 11.81% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |